JACC: CardioOncology is calling for submissions that illuminate the critical intersection of immunology, cancer and cardiovascular disease – seeking research that advances understanding of shared immune pathways, mechanisms and biomarkers that drive both oncologic and cardiovascular outcomes. Think your science can help shape this emerging field? Work exploring immune‑mediated cardiovascular injury, inflammation-driven cardiotoxicity, immunometabolism, cancer therapy-related immune effects, or emerging immune‑based treatments for cardiovascular disease is especially encouraged. Submit by May 5.